Related Experiment Video
Updated: Nov 12, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Incidence and risk factors of venous thromboembolism after percutaneous nephrolithotomy: a single-center experience
Huimin Zeng1, Meng Gao1, Jinbo Chen1
1Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Insights
The incidence of venous thromboembolism (VTE) after percutaneous nephrolithotomy (PCNL) is 2.8%. Key risk factors include discontinued anticoagulation, elevated D-dimer, hydronephrosis, higher Caprini RAM score, and postoperative sepsis.
Area of Science:
- Urology
- Nephrology
- Vascular Surgery
Background:
- Percutaneous nephrolithotomy (PCNL) is a common procedure for kidney stones.
- Venous thromboembolism (VTE) is a potential complication following surgical interventions.
- Identifying VTE risk factors in PCNL patients is crucial for prevention.
Purpose of the Study:
- To determine the incidence of VTE in patients undergoing PCNL.
- To identify independent risk factors associated with VTE after PCNL.
- To develop a predictive model for VTE risk in PCNL patients.
Main Methods:
- Retrospective review of 896 PCNL cases.
- Univariate and multivariate logistic regression analyses to identify risk factors.
- Development of a nomogram for VTE risk prediction.
Main Results:
- The overall incidence of VTE was 2.8%.
- Independent risk factors identified: discontinued anticoagulant/antiplatelet therapy, elevated postoperative D-dimer, hydronephrosis, higher Caprini RAM score, and postoperative sepsis.
- A nomogram demonstrated moderate discriminative ability (concordance index 0.731).
Conclusions:
- VTE occurs in 2.8% of patients post-PCNL.
- Patients with identified risk factors require vigilant thromboprophylaxis and early VTE detection.
- The study provides a predictive tool to aid in managing VTE risk.
Purpose:
To determine the incidence and risk factors of the venous thromboembolism (VTE) in patients undergoing percutaneous nephrolithotomy (PCNL).
Methods:
We retrospectively reviewed the records of 896 consecutive cases receiving PCNL between July 2018 and August 2020 in our institution. Univariate analysis was performed to identify the risk factors of VTE, and multivariate logistic regression analysis was further performed to determine the independent risk factors. Furthermore, the corresponding nomogram was conducted to establish a predicted model for VTE.
Results:
The overall incidence of VTE was 2.8%. The multivariate logistic regression analysis showed that discontinued anticoagulant or antiplatelet therapies (OR 4.505, 95% CI 1.410-14.401), increased postoperative 12-h D-dimer (OR 11.162, 95% CI 2.370-52.574), hydronephrosis (OR 3.303, 95% CI 1.303-8.375), higher Caprini risk assessment model (RAM) score (OR 3.233, 95% CI 1.207-8.659) and postoperative sepsis or septic shock (OR 3.784, 95% CI 1.163-12.306) were independent risk factors of VTE following PCNL. Moreover, the area under the curve of postoperative 12-h D-dimer, hydronephrosis and Caprini RAM score was 0.826, 0.621 and 0.660, respectively. Based on the identified independent risk factors, the well-calibrated nomogram showed a moderate discriminative ability with concordance index 0.731.
Conclusions:
2.8% of patients developed VTE following PCNL. Regarding those patients who have independent risk factors in this study, due attention should be paid to the effective thromboprophylaxis and the early detection of VTE.
More Related Videos
07:17Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Cardiac Catheterization I: Pre-Procedure Overview
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Venous Thrombosis III: Interprofessional Care
Acute Pyelonephritis I: Introduction
Urinary Tract Calculi IV: Nutrition Therapy and Prevention